All Qdenga articles
-
NewsCommentary: Dengue viral infection and associated liver disease
A new commentary highlights the time course of serological and liver enzyme elevations in mild versus severe dengue, emphasizes early recognition of progression to acute liver failure, and reviews current vaccination and prevention strategies.
-
NewsQdenga vaccine shows effectiveness against dengue under real-world conditions during Brazil’s 2024 outbreak
An international team of researchers has demonstrated that the tetravalent dengue vaccine Qdenga provides significant protection against the disease under real-world conditions, during the large 2024 epidemic in São Paulo, Brazil.
-
NewsDengue vaccine is effective and safe, reveals first global meta-analysis
The study, conducted by cross-referencing data from 19 scientific studies, involving over 20,000 individuals, shows an efficacy rate of over 50% in reducing disease cases, with lasting effects and a high safety profile.
-
NewsDengue vaccine protects 79.6% of those vaccinated, study shows
The single-dose Butantan-DV dengue vaccine prevents development of the disease in 79.6% of those vaccinated, according to a new study.